TRiCares SAS
TRiCares is a privately held medical device company developing Topaz, a minimally invasive transcatheter tricuspid valve replacement (TTVR) system designed to eliminate tricuspid regurgitation. The company focuses on transfemoral and transjugular delivery methods, advancing clinical studies in Europe and the US to progress toward regulatory approvals.
Leadership & Board
- Current Number of Employees
- 67
- Current LinkedIn Followers
- 3,249
Latest Estimated Valuation
- Estimated Valuation
- ―
- Total Amount Raised
- $20M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $20M
- Latest Funding Round
- Investment
- Post-Money Valuation
- ―
Company Momentum Positive
TRiCares SAS LinkedIn following is increasing, signaling rising market interest, while its workforce size remains relatively unchanged.
Employee Trend
TRiCares SAS had 67 employees as of October 12, 2026. The number of employees decreased by 1 (1.47%) week-over-week.
Social Trend
TRiCares SAS had 3,249 followers as of October 12, 2026. The number of followers increased by 28 (0.87%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jan 20, 2026 | Investment | $20.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| European Investment Bank | Investment |
Similar Companies
A snapshot of private companies similar to TRiCares SAS, helping you discover and navigate related company profiles.
